SCHEMBL7306979

SCHEMBL7306979

CCCc1nc(C(C)O)c(C(=O)OCOC(=O)C(C)(C)C)n1Cc1ccc(-c2ccccc2-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.55
AGTR2 P50052 4/20 0.55
AGT P01019 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306134 0.93 AGTR1 (0.59) AGTR1AGTR2AGT
SCHEMBL7908421 0.89 AGTR1 (0.57) AGTR1AGTR2AGT
SCHEMBL7312368 0.89 AGTR1 (0.63) AGTR1AGTR2AGT
SCHEMBL8860958 0.89 AGTR1 (0.56) AGTR1AGTR2AGT
SCHEMBL7297174 0.89 AGTR1 (0.56) AGTR1AGTR2AGT
SCHEMBL7305952 0.89 AGT (0.58) AGTR1AGTR2AGT
SCHEMBL14855713 0.87 AGTR1 (0.59) AGTR1AGTR2AGT
SCHEMBL14855463 0.87 AGTR1 (0.59) AGTR1AGTR2AGT
SCHEMBL7887862 0.86 AGTR1 (0.45) AGTR1AGTR2AGT
SCHEMBL12991387 0.86 AGT (0.56) AGTR1AGTR2AGT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed